Page 68 - 82_01
P. 68

Adolfo Toledano et al

20. Wyss-Coray T, Rogers J. Inflammation in Alzheimer          34. Toledano A, Álvarez MI, Toledano-Díaz A. Diversity
     disease-a brief review of the basic science and clinical       and variability of the nicotine effects on different
     literature. Cold Spring Harb Perspect Med 2012;                brain cortical regions. Therapeutic and toxicologic
     2:a006346.
                                                               implications. Central Nervous System Agents in
21. Meraz-Ríos MA, Toral-Ríos D, Franco-Bocanegra D,           Medicinal Chemistry 2010; 10:180-206.
     Villeda-Hernández J, Campos-Peña V. Inflammatory
     process in Alzheimer's Disease. Front Integr Neurosci     35. Alvarez MI, Rivas L, Lacruz C, Toledano A. Astroglial
     2013; 13 7:59. doi:10.3389/fnint.2013.00059.                   cell subtypes in the cerebella of normal adults, elderly

22. Town T, Nikolic V, Tan J. The microglial "activation"      adults, and patients with Alzheimer's disease: A
     continuum: from innate to adaptive responses. J           histological and immunohistochemical comparison.
     Neuroinflammation, 2005; 2:24, doi:10.1186/1742-
     2094-2-24.                                                Glia 2015; 62:287-312.

23. Colton CA. Heterogeneity of Microglial Activation in       36. Kulijewicz-Nawrot M, Syková E, Chvátal A,
     the Innate Immune Response in the Brain. J.                    Verkhratsky A, Rodríguez JJ. Astrocytes and
     Neuroimmune Pharmacol 2009; 4:399-418.                         glutamate homoeostasis in Alzheimer's disease: a

24. Boche D, Perry VH, Nicoll JA. Review: activation           decrease in glutamine synthetase, but not in glutamate
     patterns of microglia and their identification in the     transporter-1, in the prefrontal cortex. ASN Neuro
     human brain. Neuropathol Appl Neurobiol 2013;
     39:3-18.                                                  2013; 5:273-82.

25. Verkhratsky A, Marutle A, Rodríguez-Arellano JJ,           37. Franklin RJ, Goldman SA. Glia Disease and Repair-
     Nordberg A. Glial Asthenia and functional Paralysis:
     A new perspective on neurodegeneration and                Remyelination. Cold Spring Harb Perspect Biol. May
     Alzheimer's Disease. Neuroscientist 2014; 14. pii:
     1073858414547132.                                         2015;            18;7:a020594.                     doi:

26. Orre M, Kamphuis W, Osborn LM, Jansen AH,                  10.1101/cshperspect.a020594.
     Kooijman L, Bossers K, Hol EM. Isolation of glia
     from Alzheimer's mice reveals inflammation and            38. Vanzuli I, Rivera A, Arellano JJ, Butt A. Decreased
     dysfunction. Neurobiol Aging 2014; 35: 2746-60.
                                                               regenerative capacity of oligodendrocyte progenitor
27. Rodríguez JJ, Olabarria M, Chvatal A, Verkhratsky A.       cells (NG2-glia) in the ageing brain: a vicious cycle of
     Astroglia in dementia and Alzheimer's disease. Cell       synaptic dysfunction, myelin loss and neuronal
     Death Differ 2009; 16:378-85.
                                                               disruption? Curr Alzheimer Res 2016; (en prensa).
28. Verkhratsky A, Rodríguez JJ,Parpura V. Astroglia in
     neurological diseases. Future Neurol 2013; 8: 149-58.     39. Crawford AH, Stockley JH, Tripathi RB, Richardson
                                                                    WD, Franklin RJ. Oligodendrocyte progenitors: adult
29. Parpura V, Heneka MT, Montana V, Oliet SH,                      stem cells of the central nervous system? Exp Neurol
     Schousboe A, Haydon PG, et al. Glial cells in
     (patho)physiology. J Neurochem 2012; 121:4-27.            2014; 260:50-5.

30. Toledano A, Álvarez MI, Toledano-Díaz A, Merino JJ,        40. Benarroch EE. Microglia: Multiple roles in
     Rodríguez-Arellano JJ. Brain Local and regional                surveillance, circuit shaping, and response to injury.
     neuroglial alterations in Alzheimer´s Disease: Cell            Neurology 2013; 81: 1079-88.
     types, responses and implications. Curr Alzh Res
     2016; 16 (en prensa).                                     41. Tremblay ME, Stevens B, Sierra A, Wake H, Bessis A,
                                                                    Nimmerjahn A. The role of microglia in the healthy
31. Papa M, De Luca C, Petta F, Alberghina L, Cirillo G.
     Astrocyte-neuron interplay in maladaptive plasticity.     brain. J Neurosci 2011; 31:16064-9.
     Neurosci Biobehav Rev 2014; 42: 35-54.
                                                               42. Morris GP, Clark IA, Zinn R, Vissel B. Microglia: a
32. Monzón-Mayor M, Alvarez M, Arbelo-Galván J,                     new frontier for synaptic plasticity, learning and
     Romero-Alemán M, Yanes C, et al. Long-term
     evolution of local, proximal and remote astrocyte         memory, and neurodegenerative disease research.
     responses after diverse nucleus basalis lesioning (an     Neurobiol Learn Mem 2013; 105: 40-53.
     experimental Alzheimer model): GFAP
     immunocytochemical study. Brain Res 2000;                 43. Del Río-Hortega P. Microglía. In: Cytology and
     865:245-58.                                                    Cellular Pathology of the Nervous System, Vol. II.

33. Hailer NP, Grampp A, Nitsch R. Proliferation of            (Ed: Penfield W). New York: Hafner 1932: pp. 483-
     microglia and astrocytes in the dentate gyrus             534.
     following entorhinal cortex lesion: a quantitative
     bromodeoxyuridine-labelling study. Eur J Neurosci         44. Brites D, Fernandes A. Neuroinflammation and
     1999; 11:3359-64.
                                                               Depression: Microglia Activation, Extracellular
    66
                                                               Microvesicles and microRNA Dysregulation. Front
                                                               Cell Neurosci. 2015; Dec 17;9:476. doi:

                                                               10.3389/fncel.2015.00476. eCollection.

                                                               45. Sandu RE, Buga AM, Uzoni A, Petcu EB, Popa-
                                                                    Wagner A. Neuroinflammation and comorbidities are
                                                                    frequently ignored factors in CNS pathology. Neural

                                                               Regen Res 2015; Sep;10(9):1349-55. doi:
                                                               10.4103/1673-5374.165208.

                                                               46. Prinz M, Priller J, Sisodia SS, Ransohoff RM.

                                                               Heterogeneity of CNS myeloid cells and their roles in

                                                               neurodegeneration. Nat Neurosci 2011; 14:1227-35.

                                                               47. Li T, Pang S, Yu Y, Wu X, Guo J, Zhang S.

                                                               @Real Academia Nacional de Farmacia. Spain
   63   64   65   66   67   68   69   70   71   72   73